PATENT CLAIM ANALYSIS

Application Number: 15875637
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "450000"]

Abstract:
A non-toxic vehicle for hormone therapy. The non-toxic vehicle includes a cationic lipid or a neutral lipid and polyethylene glycol.

Claim (Index 3):
The non-toxic vehicle of  claim 1 , wherein the cationic lipid or the neutral lipid is selected from the group consisting of N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium chloride; dioleoylphosphatidylethanolamine; 2,3-dioleyloxy-N-[2-(spermine-carboxaindo)ethyl]-N,N-dimethyl-1-propanaminium; 5-carboxyspermylglycinedioctadecylaminde; N,N-dimethyl-N-ethylcarboxamidochloesterol; 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine; palmitoyl-sn-glycero-phosphoethanolamine; and 1,2-dimyristoyl-snglycero-3-phospho-ethanolamine.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.29412
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12394578', '11785251', '12993421', '14774163', '13060560']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7256706973338142
- 35 USC 102 Novelty (BERT): 0.4856488072786231
- Combined Prediction Score: 0.7016685083282951
- Mean Citation Score: 114.98852200000002
- Max Citation Score: 117.18805
- Similarity Product: 70.46101156766413

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test